Malfunction of the circadian clock has been linked to a wide variety of diseases, including sleep–wake disorders, obesity, diabetes, cancer, and hypertension, making the circadian clock an intriguing target for drug development. This evidence concerns the gene CLOCK and obesity due to melanocortin 4 receptor deficiency.